ExodusPoint Capital Management, LP
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1736225
NEW YORK, NY
Position in SUPN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$10,447,376
-$940,186 QoQ
Shares Held
202,116
-11.8% QoQ
Ownership
0.348%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ExodusPoint Capital Management, LP holds $58,166,201 across 15 Drug Manufacturers - Specialty & Generic names. SUPN ranks #3 (18.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
216,322 | $16,408,023 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
570,032 | $13,640,865 | |
| 3 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
202,116 | $10,447,376 | |
| 4 | ALKS |
Alkermes plc.
|
204,324 | $7,224,896 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
52,303 | $2,518,389 | |
| 6 | PRGO |
PERRIGO Co plc
|
190,050 | $2,041,137 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
161,700 | $2,009,931 | |
| 8 | BCRX |
Biocryst Pharmaceuticals Inc
|
190,058 | $1,809,352 |
All Filings in SUPN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,447,376 | 202,116 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $11,387,562 | 229,126 | Shares | Sole | 2026-02-17 | |
| 2023-03-31 | $1,718,062 | 47,421 | Shares | Other | 2023-05-11 | |
| 2022-03-31 | $1,077,645 | 33,343 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,045,969 | 35,870 | Shares | Other | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||